Name | 5-(aziridin-1-yl)-3-(hydroxymethyl)-2-[(E)-3-hydroxyprop-1-enyl]-1-methylindole-4,7-dione |
---|---|
Synonyms |
Neoquin
NOR-701 1H-Indole-4,7-dione, 5-(1-aziridinyl)-3-(hydroxymethyl)-2-(3-hydroxy-1-propen-1-yl)-1-methyl- EO-9 5-(1-Aziridinyl)-3-(hydroxymethyl)-2-(3-hydroxy-1-propen-1-yl)-1-methyl-1H-indole-4,7-dione Apaziquonum Apaziquone EOquin |
Description | Apaziquone (EO-9), an analog of Mitomycin C, is a prodrug that is activated to DNA damaging species by oxidoreductases (particularly NQO1). Apaziquone has the ability to kill aerobic and/or hypoxic cancer cells. Apaziquone, a bioreductive alkylating agent, inhibits cell proliferation and induces apoptosis in oral squamous cell carcinoma (OSCC) cells. Apaziquone significantly reduces oral tumor xenograft volume in immunocompromised NOD/SCID/Crl mice[1][2]. |
---|---|
Related Catalog | |
References |
Density | 1.5±0.1 g/cm3 |
---|---|
Boiling Point | 632.3±55.0 °C at 760 mmHg |
Molecular Formula | C15H16N2O4 |
Molecular Weight | 288.298 |
Flash Point | 336.2±31.5 °C |
Exact Mass | 288.110992 |
PSA | 82.54000 |
LogP | -1.36 |
Vapour Pressure | 0.0±2.0 mmHg at 25°C |
Index of Refraction | 1.682 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
~% 114560-48-4 |
Literature: Synthesis, , # 5 p. 633 - 636 |